Low level determinations of methyl methanesulfonate and ethyl methanesulfonate impurities in emtricitabine active pharmaceutical ingredient by LC/MS/MS using electrospray ionization

Analytical Chemistry Insights

Volumn 6, Issue 1, 2011, Pages 21-28

  Kakadiya, P R ^a   Chandrashekhar, T G ^a   Ganguly, S ^a   Singh, D K ^b   Singh, V ^a  

^a Ranbaxy Research Laboratory   (India)

^b HARCOURT BUTLER TECHNOLOGICAL INSTITUTE   (India)

Author keywords

Emtricitabine; Ethyl methanesulfonate; Genotoxic impurities; Lc ms ms; Methyl methanesulfonate; Trace analysis

Indexed keywords

EID: 80055045225     PISSN: None     EISSN: 11773901     Source Type: Journal    
DOI: 10.4137/ACI.S6471     Document Type: Article

References (12)

1. Dobo KL, Greene N, Cyr MO, Caron S, Ku WW. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. Reg Toxicol Pharm. 2006;44:282-93.
2. IARC Monographs Program on the Evaluation of Carcinogenic Risks to Humans (2004) for methyl methanesulfonate. 1999;71:1059.
3. IARC Monographs Program on the Evaluation of Carcinogenic Risks to Humans (2004) for ethyl methanesulfonate. 1974;7:245.
4. Guidelines on the Limits of Genotoxic Impurities. Committee for Medicinal Products for Human Use [CHMP]. European Medicines Agency [EMEA]. London, 2006 Jun 28:28. (CPMP/SWP/5199/02, EMEA/CHMP/QWP/251344/2006).
5. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches; US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER): Silver Spring, MD, USA, 2008 Dec
6. Kroes R, Renwick AG, Cheeseman M, Kleiner J, Mangelsdorf I, Piersma A, et al. The Threshold of Toxicological Concern Concept in Risk Assessment. Food Chem Toxicol. 2004;42:65-83.
7. Miller SA, Ju J, Cucolo M, et al. Poster at the 52nd ASMS Conference, 2004.
8. Filby WG, Gunther K, Penzhorn RD. Relative molar response of a flame ionization detector to some organic compounds containing sulfur. Anal Chem. 1975;47:2283-5.
9. Li W. Trace analysis of residual methyl methanesulfonate, ethyl methanesulfonate and isopropyl methanesulfonate in pharmaceuticals by capillary gas chromatography with flame ionization detection. J Chromator A. 2004;1046:297-301.
10. Colon I, Richoll SM. Determination of methyl and ethyl esters of methanesulfonic, benzenesulfonic and p-toluenesulfonic acids in active pharmaceutical ingredients by solid-phase microextraction (SPME) coupled to GC/SIM-MS. J Pharm Biomed Anal. 2005;39:477-85.
11. Lee CR, Guivarch F, Van Dau CN, Ressier D, Krstulovic AM. Determination of polar alkylating agents as thiocyanate/isothiocyanate derivatives by reaction headspace gas chromatography. Analyst, 2003;128:857-63.
12. Alzaga R, Ryan RW, Taylor-Worth K, Lipczynski AM, Szucs R, Sandra P. A generic approach for the determination of residues of alkylating agents in active pharmaceutical ingredients by in situ derivatisation-headspace-gas chromatography-mass spectrometry. J Pharm Biomed Anal. 2007;45:472-9.